Please enable JavaScript to continue using this application.

Compare $HRTX vs $MNOV | Chartloom

Compare

$HRTX vs $MNOV

Heron Therapeutics Inc · MediciNova Inc

HRTX

Heron Therapeutics Inc

MNOV

MediciNova Inc

Compare $HRTX vs $MNOV

Comparing Heron Therapeutics Inc and MediciNova Inc

HRTXHeron Therapeutics Inc

MNOVMediciNova Inc

HRTXHeron Therapeutics Inc

Market cap

$77M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

1.0%

YTD performance

-67.8%

52W performance

-69.9%

FCF yield

-15.8%

MNOVMediciNova Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

583.8%

YTD performance

14.3%

52W performance

24.6%

FCF yield

-12.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HRTX

MNOV

Detailed metrics comparison

HRTX

Heron Therapeutics Inc

MNOV

MediciNova Inc

Market Cap

HRTX$77M

MNOV$75M

Enterprise Value

HRTX$199M

MNOV$49M

Price

HRTX$0.41

MNOV$1.52

P/E Ratio

HRTXN/A

MNOVN/A

P/S Ratio

HRTX0.51x

MNOV81.28x

EV/Sales

HRTX1.31x

MNOV53.67x

EV/EBITDA

HRTX79.76x

MNOV0.00x

P/B Ratio

HRTX9.55x

MNOV2.35x

P/FCF Ratio

HRTXN/A

MNOVN/A

EV/FCF

HRTX-16.38x

MNOV-5.41x

PEG Ratio

HRTXN/A

MNOVN/A

Forward P/E (NTM)

HRTXN/A

MNOVN/A

Forward P/S (NTM)

HRTXN/A

MNOVN/A

Revenue (TTM)

HRTX$151M

MNOV$920K

Revenue Growth (YoY)

HRTX1.0%

MNOV583.8%

Forward Rev Growth

HRTX-1.6%

MNOV-2.9%

Gross Margin (TTM)

HRTX70.1%

MNOV37.8%

Operating Margin (TTM)

HRTX0.0%

MNOV0.0%

EBITDA Margin (TTM)

HRTX-5.8%

MNOV-1285.4%

Net Margin (TTM)

HRTX-22.5%

MNOV-1168.3%

FCF Margin (TTM)

HRTX-8.0%

MNOV-991.3%

Net Income (TTM)

HRTX$-34M

MNOV$-11M

FCF (TTM)

HRTX$-12M

MNOV$-9M

EPS (TTM)

HRTX-$0.18

MNOV-$0.22

ROE (TTM)

HRTX-30090.0%

MNOV-2651.0%

ROA (TTM)

HRTX-1357.0%

MNOV-2439.0%

ROIC (TTM)

HRTX-2233.0%

MNOV-2651.0%

Cash

HRTX$21M

MNOV$25M

Debt

HRTX$143M

MNOV$0

Net Cash/Debt

HRTX$-122M

MNOV$25M

Current Ratio (TTM)

HRTX2.49x

MNOV8.75x

Quick Ratio (TTM)

HRTX1.44x

MNOV8.58x

Debt/Equity (TTM)

HRTX20.65x

MNOV0.00x

Debt/Assets (TTM)

HRTX0.0%

MNOV0.0%

Interest Coverage (TTM)

HRTXN/A

MNOVN/A

Net Debt/EBITDA (TTM)

HRTX0.00x

MNOV0.00x

Beta

HRTX1.65

MNOV0.69

52W Performance

HRTX-69.9%

MNOV24.6%

YTD Performance

HRTX-67.8%

MNOV14.3%

% from 52W High

HRTX-74.3%

MNOV-61.0%

% from 52W Low

HRTX55.6%

MNOV30.1%

Asset Turnover (TTM)

HRTX0.60x

MNOV0.02x

FCF Yield (TTM)

HRTX-15.8%

MNOV-12.2%

Earnings Yield (TTM)

HRTX-44.3%

MNOV-14.4%

Dividend Yield (TTM)

HRTXN/A

MNOVN/A

Rule of 40

HRTX-7.0

MNOV-407.5

EV/GP/RG

HRTXN/A

MNOVN/A

Ticker research

View HRTX research View MNOV research

Metric	HRTX Heron Therapeutics Inc	MNOV MediciNova Inc
Market & Valuation
Market Cap	$77M	$75M
Enterprise Value	$199M	$49M
Price	$0.41	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	0.51x	81.28x
EV/Sales	1.31x	53.67x
EV/EBITDA	79.76x	0.00x
P/B Ratio	9.55x	2.35x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.38x	-5.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$151M	$920K
Revenue Growth (YoY)	1.0%	583.8%
Forward Rev Growth	-1.6%	-2.9%
Profitability
Gross Margin (TTM)	70.1%	37.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.8%	-1285.4%
Net Margin (TTM)	-22.5%	-1168.3%
FCF Margin (TTM)	-8.0%	-991.3%
Net Income (TTM)	$-34M	$-11M
FCF (TTM)	$-12M	$-9M
EPS (TTM)	-$0.18	-$0.22
ROE (TTM)	-30090.0%	-2651.0%
ROA (TTM)	-1357.0%	-2439.0%
ROIC (TTM)	-2233.0%	-2651.0%
Financial Health
Cash	$21M	$25M
Debt	$143M	$0
Net Cash/Debt	$-122M	$25M
Current Ratio (TTM)	2.49x	8.75x
Quick Ratio (TTM)	1.44x	8.58x
Debt/Equity (TTM)	20.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	0.69
52W Performance	-69.9%	24.6%
YTD Performance	-67.8%	14.3%
% from 52W High	-74.3%	-61.0%
% from 52W Low	55.6%	30.1%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.02x
FCF Yield (TTM)	-15.8%	-12.2%
Earnings Yield (TTM)	-44.3%	-14.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7.0	-407.5
EV/GP/RG	N/A	N/A
Ticker research	View HRTX research	View MNOV research

Valuation

P/S Ratio

HRTX

0.51x

MNOV

81.28x

EV/FCF

HRTX

-16.38x

MNOV

-5.41x

Growth & revenue

Revenue Growth TTM

MNOV

583.8%

HRTX

1.0%

Forward Revenue Growth

HRTX

-1.6%

MNOV

-2.9%

Profitability & performance

Gross Margin

HRTX

70.1%

MNOV

37.8%

ROE

MNOV

-2651.0%

HRTX

-30090.0%

FCF Yield %

MNOV

-12.2%

HRTX

-15.8%

52-Week Performance

MNOV

24.6%

HRTX

-69.9%

Detailed metrics comparison

HRTX

Heron Therapeutics Inc

MNOV

MediciNova Inc

Market Cap

HRTX$77M

MNOV$75M

Enterprise Value

HRTX$199M

MNOV$49M

Price

HRTX$0.41

MNOV$1.52

P/E Ratio

HRTXN/A

MNOVN/A

P/S Ratio

HRTX0.51x

MNOV81.28x

EV/Sales

HRTX1.31x

MNOV53.67x

EV/EBITDA

HRTX79.76x

MNOV0.00x

P/B Ratio

HRTX9.55x

MNOV2.35x

P/FCF Ratio

HRTXN/A

MNOVN/A

EV/FCF

HRTX-16.38x

MNOV-5.41x

PEG Ratio

HRTXN/A

MNOVN/A

Forward P/E (NTM)

HRTXN/A

MNOVN/A

Forward P/S (NTM)

HRTXN/A

MNOVN/A

Revenue (TTM)

HRTX$151M

MNOV$920K

Revenue Growth (YoY)

HRTX1.0%

MNOV583.8%

Forward Rev Growth

HRTX-1.6%

MNOV-2.9%

Gross Margin (TTM)

HRTX70.1%

MNOV37.8%

Operating Margin (TTM)

HRTX0.0%

MNOV0.0%

EBITDA Margin (TTM)

HRTX-5.8%

MNOV-1285.4%

Net Margin (TTM)

HRTX-22.5%

MNOV-1168.3%

FCF Margin (TTM)

HRTX-8.0%

MNOV-991.3%

Net Income (TTM)

HRTX$-34M

MNOV$-11M

FCF (TTM)

HRTX$-12M

MNOV$-9M

EPS (TTM)

HRTX-$0.18

MNOV-$0.22

ROE (TTM)

HRTX-30090.0%

MNOV-2651.0%

ROA (TTM)

HRTX-1357.0%

MNOV-2439.0%

ROIC (TTM)

HRTX-2233.0%

MNOV-2651.0%

Cash

HRTX$21M

MNOV$25M

Debt

HRTX$143M

MNOV$0

Net Cash/Debt

HRTX$-122M

MNOV$25M

Current Ratio (TTM)

HRTX2.49x

MNOV8.75x

Quick Ratio (TTM)

HRTX1.44x

MNOV8.58x

Debt/Equity (TTM)

HRTX20.65x

MNOV0.00x

Debt/Assets (TTM)

HRTX0.0%

MNOV0.0%

Interest Coverage (TTM)

HRTXN/A

MNOVN/A

Net Debt/EBITDA (TTM)

HRTX0.00x

MNOV0.00x

Beta

HRTX1.65

MNOV0.69

52W Performance

HRTX-69.9%

MNOV24.6%

YTD Performance

HRTX-67.8%

MNOV14.3%

% from 52W High

HRTX-74.3%

MNOV-61.0%

% from 52W Low

HRTX55.6%

MNOV30.1%

Asset Turnover (TTM)

HRTX0.60x

MNOV0.02x

FCF Yield (TTM)

HRTX-15.8%

MNOV-12.2%

Earnings Yield (TTM)

HRTX-44.3%

MNOV-14.4%

Dividend Yield (TTM)

HRTXN/A

MNOVN/A

Rule of 40

HRTX-7.0

MNOV-407.5

EV/GP/RG

HRTXN/A

MNOVN/A

Ticker research

View HRTX research View MNOV research

Metric	HRTX Heron Therapeutics Inc	MNOV MediciNova Inc
Market & Valuation
Market Cap	$77M	$75M
Enterprise Value	$199M	$49M
Price	$0.41	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	0.51x	81.28x
EV/Sales	1.31x	53.67x
EV/EBITDA	79.76x	0.00x
P/B Ratio	9.55x	2.35x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.38x	-5.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$151M	$920K
Revenue Growth (YoY)	1.0%	583.8%
Forward Rev Growth	-1.6%	-2.9%
Profitability
Gross Margin (TTM)	70.1%	37.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.8%	-1285.4%
Net Margin (TTM)	-22.5%	-1168.3%
FCF Margin (TTM)	-8.0%	-991.3%
Net Income (TTM)	$-34M	$-11M
FCF (TTM)	$-12M	$-9M
EPS (TTM)	-$0.18	-$0.22
ROE (TTM)	-30090.0%	-2651.0%
ROA (TTM)	-1357.0%	-2439.0%
ROIC (TTM)	-2233.0%	-2651.0%
Financial Health
Cash	$21M	$25M
Debt	$143M	$0
Net Cash/Debt	$-122M	$25M
Current Ratio (TTM)	2.49x	8.75x
Quick Ratio (TTM)	1.44x	8.58x
Debt/Equity (TTM)	20.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	0.69
52W Performance	-69.9%	24.6%
YTD Performance	-67.8%	14.3%
% from 52W High	-74.3%	-61.0%
% from 52W Low	55.6%	30.1%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.02x
FCF Yield (TTM)	-15.8%	-12.2%
Earnings Yield (TTM)	-44.3%	-14.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7.0	-407.5
EV/GP/RG	N/A	N/A
Ticker research	View HRTX research	View MNOV research